NCT05731063

Brief Summary

10 patients having deficient anterior maxilla will be recruited and a preoperative CBCT will be done to evaluate the vertical and horizontal dimensions of the intended alveolar ridge. pre-operative manufacturing of the digital surgical guides performed for Harvesting of the chin cortical bone struts from the symphysial area in the donor site and for Placement of the grafted cortical bone struts and the implant in the recipient site. Intra operatively the donor site (Chin) will be prepared to harvest autogenous bone from the chin aided by the patient's prefabricated bone harvesting guide. The recipient site (Maxillary anterior defect) will be prepared to receive the chin grafts. Grafts will be screwed in position and implants will be screwed in its preparation until it gains primary stability from basal bone, using the prefabricated bone fixation-implant placement guide. Any gaps will be filled with autogenous bone particulates from the chin. A healing tie base Abutment will be screwed into the implant through the third cortex. Primary stability will be assessed using Osstell device. An immediate postoperative CBCT will be done and superimposed on the preoperative CBCT to measure accuracy of plan transfer to make sure the planning was followed accurately. Follow up after 6 months and CBCT will be done for bone formation and density assessment and implant exposure for implant stability measurement-using osstell and removal Healing abutment and consecutive prosthetic loading.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
10

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 14, 2022

Completed
3 months until next milestone

First Posted

Study publicly available on registry

February 16, 2023

Completed
6 months until next milestone

Study Start

First participant enrolled

August 27, 2023

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 27, 2024

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 30, 2024

Completed
Last Updated

September 6, 2023

Status Verified

September 1, 2023

Enrollment Period

6 months

First QC Date

November 14, 2022

Last Update Submit

September 4, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Bone quality (change in bone density)

    Serial CBCT scans measuring change in bone density in grey value

    T0 before surgery, T1 immediately after surgery, T2 after 6 month

Secondary Outcomes (3)

  • Bone quantity (bone formation "height and width")

    T0 before surgery, T1 immediately after surgery, T2 after 6 month

  • Implant stability

    day of the surgery and at 6 month

  • Accuracy of Plan Transfer

    1-3 days postoperatively

Study Arms (1)

Ridge augmentation surgery

OTHER

Computer guided simultaneous implant placement with tri-cortical ridge augmentation using chin cortical bone struts in anterior atrophic maxilla

Procedure: Computer guided simultaneous implant placement with tri-cortical ridge augmentation using chin cortical bone struts

Interventions

fabrication of surgical guide to aid in chin bone harvesting and another guide to help for accurate placement and simultaneous placement in anterior maxillary defective area.

Ridge augmentation surgery

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with single or Multiple missing Maxillary Anterior Teeth with vertically and horizontally defective ridges having adequate soft tissue ample.
  • Patients who gave their consent for this trial.
  • Males and females will be included.

You may not qualify if:

  • Patients on bisphosphonates or drugs altering bone metabolism, within 2 months before initiating the study.
  • Subjected to irradiation in the head and neck area less than 1 year before implantation.
  • Patients allergic to drugs used in the study.
  • Patients having a history of a major medical condition (ASA 3,4)
  • Untreated periodontitis.
  • Poor oral hygiene and motivation.
  • Uncontrolled diabetes.
  • Pregnant or nursing.
  • Substance abuse.
  • Psychiatric problems or unrealistic expectations.
  • Severe bruxism or clenching.
  • Immunosuppressed or immunocompromised patients.
  • Treated or under treatment with intravenous amino-bisphosphonates.
  • Active infection or severe inflammation in the area intended for implant placement.
  • Unable to open mouth sufficiently to accommodate the surgical tooling.
  • +2 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Dentistry, Cairo University

Cairo, 11553, Egypt

RECRUITING

Central Study Contacts

Ahmed MA Abdelrahman, BDS

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dentist

Study Record Dates

First Submitted

November 14, 2022

First Posted

February 16, 2023

Study Start

August 27, 2023

Primary Completion

February 27, 2024

Study Completion

May 30, 2024

Last Updated

September 6, 2023

Record last verified: 2023-09

Locations